Monographie - Rifampicin

Última actualização :
08/05/2024

Rifampicin

Estrutura química

Nomes comerciais nos diversos países

OS NOMES COMERCIAIS SÃO INDICATIVOS E OS EXCIPIENTES DA FORMULAÇÃO PODEM SER DIFERENTES CONFORME O PAÍS E FABRICANTE.

Eremfat	Alemanha, Austria
Rif	Turquia
Rifa	Alemanha
Rifadin	Australia, Estados Unidos de América, Gran-bretanha, Irã, Irlanda, Itália, Nova Zelândia, Países Baixos, Suècia
Rifadine	Bélgica, França, Marrocos
Rifaldin	Espanha, Irã
Rifampicin	Alemanha
Rifampicina	Argentina, Equator
Rifampin	Estados Unidos de América
Rifoldin	Austria
Rimactan	Suicia
Rimactane	Irlanda

Bibliografía : Rifampicin

	Tipo	Publicação
198	Jornal	Gayed AA, Kheshary PR, Hinkle RL. Visual compatibility of diltiazem injection with various diluents and medications during simulated Y-site injection. Am J Health-Syst Pharm 1995 ; 52: 516-520.
263	Jornal	Pearson SD, Trissel LA. Stability and compatibility of minocycline hydrochloride and rifampicin in intravenous solutions at various temperatures. Am J Hosp Pharm 1993 ; 50: 698-702.
2139	Jornal	Serrurier C, Chenot ED, Vigneron J, May I, Demor? B. Assessment of injectable drug’s administration in two intensive care units and determination of potential physico-chemical incompatibilities. EJHP Science 2006 ; 12,5: 96-99.
3379	Jornal	Fox L.M, Wilder A.G, Foushee J.A. Physical compatibility of various drugs with neonatal total parenteral nutrient solution during simulated Y-site administration. Am J Health-Syst Pharm 2013 ;70:520-524.
3541	Laboratório	Rifampicin (Rifadin®) – Summary of Product Characteristics Sanofi 2011
4405	Jornal	Ezquer-Garin C, Ferriols-Lisart R, Martinez-López LM, Sangrador-Pelluz C, Nicolás-Picó J, Alós-Almiñana M. Stability of tedizolid phosphate-sodium rifampicin and tedizolid phosphate-meropenem admixtures in intravenous infusion bags stored at different temperatures Pharmazie 2020 ; 75: 172-176.
4543	Jornal	Senarathna G, Strunk T, Petrovski M, Batty K. Physical compatibility of pentoxifylline and intravenous medications. Archives of Disease in Childhood 2018 ;104:292–295.

Mentions Légales